An in-depth investigation of serum Krebs von den Lungen-6 and other biomarkers in COVID-19 severity and mortality
{{output}}
Krebs von den Lungen-6 (KL-6) is a glycoprotein mainly expressed by type II pneumocytes and recently known as a lung injury biomarker. However, the number of studies is still limited, especially in Indonesian COVID-19 populations. Therefore, we aim to provide ... ...
